Tuesday, May 22, 2012

Obamacare - #3907 - Cardinal Dolan of New York, Cardinal Wverl of D.C. Notre Dame - And 40 Other Catholic Dioceses and Organizations - Sue Obama Administration - CNS News (2) Backroom Obamacare Deal With Pharmaceutical Industry Probed by GOP - Daily Caller

The archdiocese of New York, headed by Cardinal Timothy Dolan, the archdiocese of Washington, D.C., headed by Cardinal Donald Wuerl, the University of Notre Dame, and 40 other Catholic dioceses and organizations around the country announced on Monday that they are suing the Obama administration for violating their freedom of religion, which is guaranteed by the First Amendment to the Constitution. The dioceses and organizations, in different combinations, are filing 12 different lawsuits filed in federal courts around the country. The Archdiocese of Washington, D.C. has established a special website--preservereligiousfreedom.org--to explain it lawsuit and present news and development concerning it. "This lawsuit is about an unprecedented attack by the federal government on one of America’s most cherished freedoms: the freedom to practice one’s religion without government interference," the archdiocese says on the website. "It is not about whether people have access to certain services; it is about whether the government may force religious institutions and individuals to facilitate and fund services which violate their religious beliefs." Read more.........

Backroom Obamacare Deal Probed by GOP - Daily Caller - GOP legislators are alleging that White House officials cut a secret deal in June 2009 with the pharmaceutical industry to clinch passage of Obamacare. “Based on email exchanges and other primary source material … top personnel in the White House were involved in negotiating and approving this deal,” reads a memo released by Republicans on the House Energy and Commerce Committee, which is chaired by Rep. Fred Upton. The memo’s release suggests that Republican legislators will step up efforts to investigate the deal, which helped allow the administration to impose tight and intrusive regulation over one-seventh of the nation’s economy. ”The important question to answer is what did the White House get in return” for the deal, said the May 16 memo, which also described the White House’s refusal to cooperate with the House investigators. The 2009 deal may have won the drug industry’s backing for the unpopular law in exchange for a Democratic promise to protect the drug companies’ revenues and profits from profit-sapping regulations, such as price caps on drugs. Read more..........

No comments:

Post a Comment